315 related articles for article (PubMed ID: 8100682)
1. Effect of routine use of therapy in slowing the clinical course of human immunodeficiency virus (HIV) infection in a population-based cohort.
Longini IM; Clark WS; Karon JM
Am J Epidemiol; 1993 Jun; 137(11):1229-40. PubMed ID: 8100682
[TBL] [Abstract][Full Text] [Related]
2. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
Chaisson RE; Keruly J; Richman DD; Moore RD
Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
[TBL] [Abstract][Full Text] [Related]
3. Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study.
Hoover DR; Saah AJ; Bacellar H; Phair J; Detels R; Anderson R; Kaslow RA
N Engl J Med; 1993 Dec; 329(26):1922-6. PubMed ID: 7902536
[TBL] [Abstract][Full Text] [Related]
4. Use of therapeutic and prophylactic drugs for AIDS by homosexual and bisexual men in three US cities.
Holmberg SD; Conley LJ; Buchbinder SP; Judson FN; Bush TJ; Katz MH; Penley KA; Hershow RC
AIDS; 1993 May; 7(5):699-704. PubMed ID: 8318177
[TBL] [Abstract][Full Text] [Related]
5. Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. The Multicenter AIDS Cohort Study.
Graham NM; Zeger SL; Park LP; Phair JP; Detels R; Vermund SH; Ho M; Saah AJ
Lancet; 1991 Aug; 338(8762):265-9. PubMed ID: 1677108
[TBL] [Abstract][Full Text] [Related]
6. Changes in AIDS survival time in two San Francisco cohorts of homosexual men, 1983 to 1993.
Osmond D; Charlebois E; Lang W; Shiboski S; Moss A
JAMA; 1994 Apr; 271(14):1083-7. PubMed ID: 7908703
[TBL] [Abstract][Full Text] [Related]
7. Population-based estimates of antiretroviral therapy and anti-Pneumocystis prophylaxis in San Francisco: 1991.
Lang W; Osmond D; Page-Bodkin K; Moss A; Winkelstein W
J Acquir Immune Defic Syndr (1988); 1993 Feb; 6(2):191-5. PubMed ID: 8381868
[TBL] [Abstract][Full Text] [Related]
8. The effects on survival of early treatment of human immunodeficiency virus infection.
Graham NM; Zeger SL; Park LP; Vermund SH; Detels R; Rinaldo CR; Phair JP
N Engl J Med; 1992 Apr; 326(16):1037-42. PubMed ID: 1347907
[TBL] [Abstract][Full Text] [Related]
9. Population-based estimates of zidovudine and aerosol pentamidine use in San Francisco: 1987-1989.
Lang W; Osmond D; Samuel M; Moss A; Schrager L; Winkelstein W
J Acquir Immune Defic Syndr (1988); 1991; 4(7):713-6. PubMed ID: 1675679
[TBL] [Abstract][Full Text] [Related]
10. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group.
Girard PM; Landman R; Gaudebout C; Olivares R; Saimot AG; Jelazko P; Gaudebout C; Certain A; Boué F; Bouvet E
N Engl J Med; 1993 May; 328(21):1514-20. PubMed ID: 8479488
[TBL] [Abstract][Full Text] [Related]
11. Prevention of lung infections associated with human immunodeficiency virus infection.
Hopewell PC
Thorax; 1989 Dec; 44(12):1038-44. PubMed ID: 2575801
[TBL] [Abstract][Full Text] [Related]
12. Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study.
Mussini C; Pezzotti P; Govoni A; Borghi V; Antinori A; d'Arminio Monforte A; De Luca A; Mongiardo N; Cerri MC; Chiodo F; Concia E; Bonazzi L; Moroni M; Ortona L; Esposito R; Cossarizza A; De Rienzo B
J Infect Dis; 2000 May; 181(5):1635-42. PubMed ID: 10823763
[TBL] [Abstract][Full Text] [Related]
13. [Impact of zidovudine treatment and the pneumocystis carinii prophylaxis in natural history of patients with HIV infection].
Sáiz Hervas E; Castilla Castellano V; Miquel Plaza J; Benito Blanco AM; Martín Llorens MM; Pastor de Blas M; Izquierdo P; Muñoz Jareño MA; Sierra A; Nieto MA; Moreno Collado AM; Fraguas C
An Med Interna; 1998 Mar; 15(3):132-7. PubMed ID: 9580410
[TBL] [Abstract][Full Text] [Related]
14. Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok, Thailand.
Wannamethee SG; Sirivichayakul S; Phillips AN; Ubolyam S; Ruxrungtham K; Hanvanich M; Phanuphak P
Int J Epidemiol; 1998 Apr; 27(2):289-95. PubMed ID: 9602412
[TBL] [Abstract][Full Text] [Related]
15. Lower survival in AIDS patients receiving dapsone compared with aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia. Study Group.
Salmon-Ceron D; Fontbonne A; Saba J; May T; Raffi F; Chidiac C; Patey O; Aboulker JP; Schwartz D; Vildé JL
J Infect Dis; 1995 Sep; 172(3):656-64. PubMed ID: 7658056
[TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency virus infection in children.
Hoernle EH; Reid TE
Am J Health Syst Pharm; 1995 May; 52(9):961-79. PubMed ID: 7641035
[TBL] [Abstract][Full Text] [Related]
17. A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group.
Bozzette SA; Finkelstein DM; Spector SA; Frame P; Powderly WG; He W; Phillips L; Craven D; van der Horst C; Feinberg J
N Engl J Med; 1995 Mar; 332(11):693-9. PubMed ID: 7854375
[TBL] [Abstract][Full Text] [Related]
18. Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia. The San Francisco community prophylaxis trial.
Leoung GS; Feigal DW; Montgomery AB; Corkery K; Wardlaw L; Adams M; Busch D; Gordon S; Jacobson MA; Volberding PA
N Engl J Med; 1990 Sep; 323(12):769-75. PubMed ID: 1975426
[TBL] [Abstract][Full Text] [Related]
19. The effects of long term zidovudine therapy and Pneumocystis carinii prophylaxis on HIV disease. A review of the literature.
Hoover DR
Drugs; 1995 Jan; 49(1):20-36. PubMed ID: 7705214
[TBL] [Abstract][Full Text] [Related]
20. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021.
Hardy WD; Feinberg J; Finkelstein DM; Power ME; He W; Kaczka C; Frame PT; Holmes M; Waskin H; Fass RJ
N Engl J Med; 1992 Dec; 327(26):1842-8. PubMed ID: 1448121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
